首页> 外文期刊>BMC Pulmonary Medicine >Asthma–COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study
【24h】

Asthma–COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study

机译:四个拉丁美洲国家的初级保健中的哮喘-COPD重叠综合征(ACOS):PUMA研究

获取原文
           

摘要

Background Asthma–COPD overlap syndrome (ACOS) prevalence varies depending on the studied population and definition criteria. The prevalence and clinical characteristics of ACOS in an at-risk COPD primary care population from Latin America was assessed. Methods Patients ≥40?years, current/ex-smokers and/or exposed to biomass, attending routine primary care visits completed a questionnaire and performed spirometry. COPD was defined as post-bronchodilator forced expiratory volume in 1?s/forced vital capacity (FEV1/FVC)?1 or FVC ≥200?mL and ≥12%); ACOS was defined using a combination of COPD with the two asthma definitions. Exacerbations in the past year among the subgroups were evaluated. Results One thousand seven hundred forty three individuals completed the questionnaire, 1540 performed acceptable spirometry, 309 had COPD, 231 had prior asthma diagnosis, and 78 asthma by wheezing?+?reversibility. ACOS prevalence in the total population (by post-bronchodilator FEV1/FVC?1/FVC?1/FVC?Conclusions ACOS prevalence in primary care varied according to definition used. ACOS by post-bronchodilator FEV1/FVC
机译:背景哮喘-COPD重叠综合征(ACOS)的患病率取决于所研究的人群和定义标准。评估了拉丁美洲高危COPD初级保健人群中ACOS的患病率和临床特征。方法≥40岁,现/现吸烟者和/或暴露于生物质的患者,参加常规的初级保健就诊,完成问卷并进行肺活量测定。 COPD定义为支气管扩张剂后呼气量以1?s /强迫肺活量(FEV 1 / FVC)?1 或FVC≥200?mL和≥12%)定义;结合COPD和两种哮喘定义定义了ACOS。对亚组中去年的病情加重进行了评估。结果173例患者完成了问卷调查,1540例患者接受了肺活量测定,309例患有COPD,231例先前诊断为哮喘,78例喘息+可逆性哮喘。总人口中的ACOS患病率(按支气管扩张剂后FEV 1 / FVC?1 / FVC?1 / FVC?的结论)根据所使用的定义,初级保健中的ACOS患病率有所不同。通过支气管扩张剂FEV 1 / FVC进行的ACOS

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号